Physician profile
Laura N Phillips
NPI 1154048387
$2,134.85
in general payments reported to CMS, 2019-2025
20 companies · $1,588 in 2025
The $1,588 reported for 2025 was more than what 88% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $349 · 2024: $198 · 2025: $1,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,134.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $402.65 | 2024-2025 | Saphnelo |
| Amgen INC. | $329.72 | 2025 | Tavneos, Uplizna |
| Ucb, INC. | $243.76 | 2025 | Bimzelx |
| Abbvie INC. | $228.90 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $161.57 | 2023-2025 | Camzyos, Eliquis |
| Insmed, INC. | $147.20 | 2024 | Arikayce |
| Csl Behring | $119.50 | 2025 | Kcentra |
| Baxter Healthcare | $116.35 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Vertex Pharmaceuticals Incorporated | $92.64 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.70 | 2025 | Hyqvia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.69 | 2025 | |
| Sanofi-Aventis U.S. LLC | $37.72 | 2023 | |
| Tonix Medicines, INC. | $24.28 | 2025 | Zembrace Symtouch |
| Glaxosmithkline, LLC. | $23.69 | 2025 | Benlysta |
| Sun Pharmaceutical Industries INC. | $19.39 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.07 | 2025 | Mounjaro, Zepbound |
| Medline Industries LP | $18.97 | 2023 | |
| Merck Sharp & Dohme LLC | $16.42 | 2023 | Verquvo |
| Medtronic, INC. | $15.37 | 2024 | Intellis Adaptivestim |
| Irhythm Technologies, INC. | $14.26 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.